| pubmed-article:10337662 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10337662 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:10337662 | lifeskim:mentions | umls-concept:C0079488 | lld:lifeskim |
| pubmed-article:10337662 | lifeskim:mentions | umls-concept:C0017152 | lld:lifeskim |
| pubmed-article:10337662 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
| pubmed-article:10337662 | lifeskim:mentions | umls-concept:C1880198 | lld:lifeskim |
| pubmed-article:10337662 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:10337662 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10337662 | pubmed:dateCreated | 1999-7-19 | lld:pubmed |
| pubmed-article:10337662 | pubmed:abstractText | H. pylori infection leads to the formation of autoantibodies against canalicular structures with human parietal cells in about 30% of all patients. This type of autoreactivity is associated with gastric mucosa atrophy. This study aimed to analyse the effect of cure of infection on anticanalicular autoantibodies. H. pylori infection was cured in 34 patients. Sera of these patients were screened for anticanalicular autoantibodies using an immunohistochemical method before, 10 weeks after and one year after cure of infection. Prevalence of anticanalicular autoantibodies significantly decreased from 26% before treatment to 9% after one year. The data presented in this study add new information to the possible reversibility of gastric mucosa atrophy. | lld:pubmed |
| pubmed-article:10337662 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10337662 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10337662 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10337662 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10337662 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10337662 | pubmed:issn | 0344-0338 | lld:pubmed |
| pubmed-article:10337662 | pubmed:author | pubmed-author:WinterMM | lld:pubmed |
| pubmed-article:10337662 | pubmed:author | pubmed-author:SteiningerHH | lld:pubmed |
| pubmed-article:10337662 | pubmed:author | pubmed-author:KirchnerTT | lld:pubmed |
| pubmed-article:10337662 | pubmed:author | pubmed-author:BayerdörfferE... | lld:pubmed |
| pubmed-article:10337662 | pubmed:author | pubmed-author:NorsR ARA | lld:pubmed |
| pubmed-article:10337662 | pubmed:author | pubmed-author:FallerGG | lld:pubmed |
| pubmed-article:10337662 | pubmed:author | pubmed-author:MeiningAA | lld:pubmed |
| pubmed-article:10337662 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10337662 | pubmed:volume | 195 | lld:pubmed |
| pubmed-article:10337662 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10337662 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10337662 | pubmed:pagination | 243-6 | lld:pubmed |
| pubmed-article:10337662 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:meshHeading | pubmed-meshheading:10337662... | lld:pubmed |
| pubmed-article:10337662 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10337662 | pubmed:articleTitle | Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection. | lld:pubmed |
| pubmed-article:10337662 | pubmed:affiliation | Institute of Pathology, University of Erlangen-Nürnberg, Germany. Gerhard.Faller@patho.med.uni-erlangen.de | lld:pubmed |
| pubmed-article:10337662 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10337662 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10337662 | lld:pubmed |
